All Thayer News
Adagio Therapeutics CEO: We See a Role in the Treatment of Covid, as Well as Prevention
Nov 29, 2021 | CNBC
Tillman Gerngross, [Dartmouth Engineering professor and] Adagio Therapeutics CEO, joins 'The Exchange' to discuss how his company's antibody drug was developed and its effectiveness in fighting Covid variants.
Link to source:
For contacts and other media information visit our Media Resources page.